DHI Stock Analysis — DR Horton
Sector: Homebuilders
AI Verdict
DHI trades at a cheap multiple for the sector, but with almost no growth ahead, the low price reflects a business treading water despite its scale moat.
Competitive Moat
DR Horton is the largest U.S. homebuilder by volume, giving it scale advantages in land acquisition, supplier negotiations, and distribution. Its national footprint and deep relationships with subcontractors make it harder for smaller rivals to compete on cost and delivery speed.
Summary
DHI's RSI of 25.5 signals the stock is deeply oversold after muted forward growth expectations.
Where It Stands
The stock is up 10.34% over the past year, trades at 13.4x next year's earnings (below the 20x industrials median), but with just 1.4% forward EPS growth and an RSI of 25.5, it's oversold but not growing much.
Key Metrics
- RSI: 25.5 — Oversold
- Trailing P/E: 13.6x
- Forward P/E: 13.4x
- PEG Ratio: 3.02
- Earnings Growth: +0.0%
- Revenue Growth: -0.1%
- Market Cap: $41.1B
- Dividend Yield: 0.01%
- 1-Year Return: 10.34%
- 52-Week High: $184.55
- 52-Week Low: $129.22
Analyst Consensus
9 Buy · 16 Hold · 1 Sell (26 analysts)
Bull Case
At 13.4x forward earnings, you're paying less than the sector median for a company with the scale to weather downturns.
Bear Case
With only 1.4% EPS growth expected and a trailing PEG of 3.02, any further P/E compression could erase recent gains.
Catalyst to Watch
Watch for new home sales data or mortgage rate shifts, as a pickup could quickly improve growth expectations.